Mehmet Cansev

Title: Innovations of Mehmet Cansev in Neurological Health

Introduction

Mehmet Cansev is a notable inventor based in Bursa, Turkey. He has made significant contributions to the field of neurological health, particularly in the treatment of white matter lesions in the elderly. His innovative approach focuses on utilizing specific compounds to address age-related neurological conditions.

Latest Patents

Cansev holds a patent for a method aimed at reducing white matter lesions, white matter hyperintensities (WMH), leukoaraiosis, or periventricular white matter disease in elderly individuals. The invention involves the use of one or more of uridine and cytidine, along with their salts, phosphates, acyl derivatives, or esters, in the formulation of a composition designed to treat, prevent, or reduce the risk of these conditions. This invention is particularly relevant for non-demented elderly individuals and those not suffering from Alzheimer's Disease. The compositions developed by Cansev have been found to effectively control Nogo-A protein levels, leading to potential therapeutic benefits.

Career Highlights

Cansev is associated with N.V. Nutricia, where he continues to work on innovative solutions in the field of health and nutrition. His research and development efforts are focused on improving the quality of life for elderly patients through advanced medical compositions.

Collaborations

Cansev has collaborated with notable colleagues, including Nick Van Wijk and Robert Johan Joseph Hageman, to further enhance the impact of his inventions in the medical community.

Conclusion

Mehmet Cansev's contributions to the field of neurological health through his innovative patent demonstrate his commitment to improving the lives of the elderly. His work continues to pave the way for advancements in the treatment of age-related neurological conditions.